These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2560496)

  • 1. Seizure-triggering mechanisms in the kindling model of epilepsy: collapse of GABA-mediated inhibition and activation of NMDA receptors.
    Morimoto K
    Jpn J Psychiatry Neurol; 1989 Sep; 43(3):459-63. PubMed ID: 2560496
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizure-triggering mechanisms in the kindling model of epilepsy: collapse of GABA-mediated inhibition and activation of NMDA receptors.
    Morimoto K
    Neurosci Biobehav Rev; 1989; 13(4):253-60. PubMed ID: 2558330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of NMDA receptors in epilepsy: I. Effects of NMDA receptor antagonists (CPP and MK-801) on amygdala kindling in rats.
    Katayama K; Morimoto K; Sato K; Ohnishi M; Okamoto M; Otsuki S
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):451-2. PubMed ID: 2147961
    [No Abstract]   [Full Text] [Related]  

  • 6. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.
    McNamara JO; Russell RD; Rigsbee L; Bonhaus DW
    Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy.
    Stelzer A; Slater NT; ten Bruggencate G
    Nature; 1987 Apr 16-22; 326(6114):698-701. PubMed ID: 2882427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor complex and kindling mechanisms.
    Morimoto K; Sato M
    Epilepsy Res Suppl; 1992; 9():297-305. PubMed ID: 1337443
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for the activation of the N-methyl-D-aspartate receptor during epileptiform discharge.
    King GL; Dingledine R
    Adv Exp Med Biol; 1986; 203():465-74. PubMed ID: 2878569
    [No Abstract]   [Full Text] [Related]  

  • 11. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat.
    Gilbert ME; Mack CM
    Brain Res; 1990 Jun; 519(1-2):89-96. PubMed ID: 2204470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor dependent paroxysmal discharges in the dentate gyrus.
    Stringer JL; Lothman EW
    Neurosci Lett; 1988 Sep; 92(1):69-75. PubMed ID: 2847090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic effects of MK-801, a noncompetitive NMDA-receptor antagonist, in the low-frequency kindling model of epilepsy.
    Minabe Y; Emori K; Shibata R; Kurachi M
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):755-61. PubMed ID: 1487858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the NMDA receptor antagonist, MK-801, on the course and outcome of kindling.
    Mintz M; Rose IC; Herberg LJ
    Pharmacol Biochem Behav; 1990 Apr; 35(4):815-21. PubMed ID: 2161108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NMDA receptors in epilepsy: II. Effects of NMDA receptor antagonists (CPP and MK-801) on hippocampal long-term potentiation in anesthetized rats.
    Morimoto K; Katayama K; Sato K; Ohnishi M; Okamoto M; Otsuki S
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):453-4. PubMed ID: 2175367
    [No Abstract]   [Full Text] [Related]  

  • 16. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
    Stasheff SF; Anderson WW; Clark S; Wilson WA
    Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the anticonvulsant effect of gamma-aminobutyric acid agonists in the feline kindling model of epilepsy.
    Morimoto K; Sanei T; Sato K
    Epilepsia; 1993; 34(6):1123-9. PubMed ID: 8243367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of N-methyl-D-aspartate (NMDA)-induced kindling.
    Croucher MJ; Cotterell KL; Bradford HF
    Biochem Soc Trans; 1996 May; 24(2):295S. PubMed ID: 8736953
    [No Abstract]   [Full Text] [Related]  

  • 19. NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures.
    Kapur J; Lothman EW
    Epilepsy Res; 1990 Mar; 5(2):103-11. PubMed ID: 2158437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of N-methyl-D-aspartate antagonist on entorhinal responses by amygdala kindling stimulations.
    Hirayama K; Miyagi N; Nakajima S; Kawawaki H; Murata R; Matsuura S
    Jpn J Psychiatry Neurol; 1992 Jun; 46(2):521-2. PubMed ID: 1434204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.